Antti Koivisto

13.03.2021 • News • Strategy

Weylchem Advanced Intermediates Broadens Scope of Market Activities

CHEManager Interview with Antti Koivisto and Michael Badine, WeylChem Advanced Intermediates

07.07.2020 • Topics • Strategy

Line Products as a Growth Market

The WeylChem Group of companies consists of seven operating and two R&D sites in Europe and the USA as well as the global sales and marketing platform, WeylChem International.

Top-Feature

Concept Heidelberg

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Interview

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

WeylChem International GmbH

Antti Koivisto

Weylchem Advanced Intermediates Broadens Scope of Market Activities

Line Products as a Growth Market

Top-Feature

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

A successful concept on course for expansion — maintenance Munich 2025

Digitalization in the Chemical Industry

20 Years of CHEManager International

Advanced Recycling Conference 2025: New Paths to the Circular Economy

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Interview

Stability in Motion

Newsletter & e-edition